FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Heterocyclic Anticancer Agents

Bimal Krishna Banik
    Product form
      FORMAT: Hardback

      R 11,556.17 Price and availability exclusive to website

      YOU COULD EARN 11,556.17 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 1,926.02 per month!
      3x monthly payments of R 3,852.05 with
      4x fortnightly payments of R 2,889.04 with
      Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.
      Format: Hardback CONTRIBUTORS: Bimal Krishna Banik EAN: 9783110739268 COUNTRY: Germany PAGES: WEIGHT: 1017 g HEIGHT: 240 cm
      PUBLISHED BY: De Gruyter DATE PUBLISHED: 2022-06-21 CITY: GENRE: MEDICAL / Biochemistry, MEDICAL / Pharmacology, SCIENCE / Life Sciences / Biochemistry, SCIENCE / Chemistry / Clinical, SCIENCE / Chemistry / Organic WIDTH: 170 cm SPINE:

      Book Themes:

      Pre-clinical medicine: basic sciences, Pharmacology, Organic chemistry, Biochemistry, Industrial chemistry and chemical engineering

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.
      Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.
      Format: Hardback CONTRIBUTORS: Bimal Krishna Banik EAN: 9783110739268 COUNTRY: Germany PAGES: WEIGHT: 1017 g HEIGHT: 240 cm
      PUBLISHED BY: De Gruyter DATE PUBLISHED: 2022-06-21 CITY: GENRE: MEDICAL / Biochemistry, MEDICAL / Pharmacology, SCIENCE / Life Sciences / Biochemistry, SCIENCE / Chemistry / Clinical, SCIENCE / Chemistry / Organic WIDTH: 170 cm SPINE:

      Book Themes:

      Pre-clinical medicine: basic sciences, Pharmacology, Organic chemistry, Biochemistry, Industrial chemistry and chemical engineering

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account